BlackRock Fund Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8.11M	Buy	2,568,374 +338,900	+15%	+$1.04M	﹤0.01%	2690
2016 Q3	$7.61M	Buy	2,229,474 +314,517	+16%	+$869K	﹤0.01%	2625
2016 Q2	$4.37M	Buy	1,914,957 +238,445	+14%	+$585K	﹤0.01%	2870
2016 Q1	$4.21M	Sell	1,676,512 -219,749	-12%	-$490K	﹤0.01%	2830
2015 Q4	$6.28M	Buy	1,896,261 +169,190	+10%	+$506K	﹤0.01%	2710
2015 Q3	$4.18M	Sell	1,727,071 -17,167	-1%	-$44.4K	﹤0.01%	2893
2015 Q2	$5.11M	Sell	1,744,238 -48,685	-3%	-$189K	﹤0.01%	2911
2015 Q1	$7.19M	Buy	1,792,923 +34,391	+2%	+$119K	﹤0.01%	2628
2014 Q4	$5.29M	Buy	1,758,532 +264,468	+18%	+$715K	﹤0.01%	2845
2014 Q3	$3.79M	Sell	1,494,064 -58,694	-4%	-$141K	﹤0.01%	2901
2014 Q2	$3.82M	Buy	1,552,758 +246,132	+19%	+$556K	﹤0.01%	2981
2014 Q1	$3.47M	Buy	1,306,626 +69,226	+6%	+$204K	﹤0.01%	3009
2013 Q4	$3.6M	Sell	1,237,400 -55,165	-4%	-$167K	﹤0.01%	2998
2013 Q3	$3.96M	Buy	1,292,565 +149,915	+13%	+$474K	﹤0.01%	2950
2013 Q2	$3.65M	Buy	+1,142,650	New	+$3.66M	﹤0.01%	2897